Nanologica is attending the Drug Delivery to the Lungs conference (DDL) during Dec 9-11.
The DDL is the premier conference and industry exhibition which is dedicated to pulmonary and nasal drug delivery. The focus is on providing a forum to present t recent developments in the field of inhalation therapy.
Representing Nanologica is Prof. Adam Feiler, CTO.